Since 2009, Novo Nordisk A-S (NVO) has returned 2,736.7% and the Nasdaq Composite (IXIC) has returned 1,173.6%.
| DATE | the Nasdaq Composite | Novo Nordisk A-S |
|---|---|---|
December 2024 | $20,109.06 | $108.01 |
November 2024 | $19,218.17 | $106.80 |
October 2024 | $18,095.15 | $111.95 |
September 2024 | $18,189.17 | $119.07 |
August 2024 | $17,713.62 | $139.16 |
July 2024 | $17,599.40 | $132.13 |
June 2024 | $17,732.60 | $142.20 |
May 2024 | $16,735.02 | $134.77 |
April 2024 | $15,657.82 | $127.83 |
March 2024 | $16,379.46 | $127.92 |
February 2024 | $16,091.92 | $118.47 |
January 2024 | $15,164.01 | $113.49 |
December 2023 | $15,011.35 | $102.32 |
November 2023 | $14,226.22 | $100.73 |
October 2023 | $12,851.24 | $95.52 |
September 2023 | $13,219.32 | $89.95 |
August 2023 | $14,034.97 | $91.80 |
July 2023 | $14,346.02 | $79.29 |
June 2023 | $13,787.92 | $79.65 |
May 2023 | $12,935.29 | $78.98 |
April 2023 | $12,226.58 | $82.24 |
March 2023 | $12,221.91 | $78.33 |
February 2023 | $11,455.54 | $68.85 |
January 2023 | $11,584.55 | $67.77 |
December 2022 | $10,466.48 | $66.09 |
